EN DE
Watch Colgate-Palmolive (India) Limited for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

Colgate-Palmolive (India) Limited (500830) fair value: what the stock is really worth

As of Nov 19, 2026: fair value (intrinsic value) of Colgate-Palmolive (India) Limited stock ₹787, price ₹1,775, that is 55.7% below the price, quality 86 out of 100. Rating: strongly overvalued. Calculated from audited financials with 25 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive IN

CP Some data Nov 19, 2026

Colgate-Palmolive (India) Limited

500830 · BSE

Far too expensive (fair value 56% below the price) and falling price, but strong company: meets 1 of 3 rules.

Follow free in the weekly email
Quality 86/100 
Highly profitable · 22.1% net margin (FY2025) 
Low debt 
Generates free cash flow 
Ranks above peers (8/11) 
Wide moat 92/100
Mixed Growth (revenue 5y +4.3 %/yr in INR) 
Some data 
Fair value ₹787.06 · Strongly overvalued 
Falling price (downtrend) 
Watch Colgate-Palmolive (India) Limited for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹3,685 ₹1,259 Fair Value ₹787.06 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 19, 2026.

How to read this chart

60‑month range ₹1,259 – ₹3,685 · fair‑value band ₹580.07 – ₹1,040 · the ₹1,775 price screens above the ₹787.06 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 19, 2026.

Follow Colgate-Palmolive (India) in your weekly email

Every Wednesday you see whether Colgate-Palmolive (India) is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Stock analysis

Colgate-Palmolive (India) Limited (500830) currently trades at ₹1,775, while our model-based Fair Value estimate is ₹787.06, 56% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of ₹874.63 per share, and 0 of the 25 models we run sit above the ₹1,775 price.

Bear case: the Economic Profit group reads lowest at ₹329.33, and 25 of the 25 models stay below the price. Data coverage for this calculation is medium.

Scenario range: ₹580.07 (bear) to ₹1,040 (bull), the price of ₹1,775 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 86/100 (high quality), in the Consumer Defensive sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Colgate-Palmolive (India) Limited reported revenue of ₹59.8B in FY2025 versus ₹51.0B in FY2021, a compound +4.1%/yr. Reported net income was ₹13.3B in FY2025, compounding +5.3%/yr from FY2021.

Key figures

Market cap ₹483B (≈ $5.2B) Mid · P/E ratio 45.0 · P/S ratio 9.96 · EPS (TTM) ₹38.07 · Dividend yield 3.0% · Net margin 22.1% · Return on equity 7,503% · Return on assets (EBIT) 51.8% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 92 out of 100 (medium confidence).

What moves the price

The share trades about 22% below its 52-week high and 13% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −29% fair-value upside, at −56%, 500830 screens richer than that median.

Fair Value models

Bear ₹580.07 Fair Value ₹787.06 Bull ₹1,040
Price ₹1,775 · Downside -55.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 11 months old). Earnings retained since then (₹33.79 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF ₹583.94 ₹753.58 ₹953.71 82
Growth DCF ₹589.20 ₹740.91 ₹911.53 80
Owner Earnings ₹597.26 ₹771.18 ₹976.34 78
All 25 models by family
DCF Models
FCF DCF ₹583.94 ₹753.58 ₹953.71 82
Owner Earnings ₹597.26 ₹771.18 ₹976.34 78
5Y Revenue Exit ₹414.34 ₹533.68 ₹674.71 74
5Y EBITDA Exit ₹626.32 ₹913.59 ₹1,234 76
5Y P/E Exit ₹675.08 ₹1,001 ₹1,327 71
10Y Revenue Exit ₹481.47 ₹593.85 ₹724.75 68
10Y EBITDA Exit ₹601.17 ₹815.69 ₹1,078 69
10Y P/E Exit ₹627.51 ₹866.71 ₹1,136 65
Earnings-Based
Graham-Dodd ₹343.40 ₹855.22 ₹1,109 65
PEG = 1.0 ₹439.94 ₹628.48 ₹817.02 57
EPV ₹428.95 ₹474.45 ₹511.47 71
Dividend Discount
Gordon GGM ₹372.01 ₹584.60 ₹785.24 68
DDM Multi-Stage ₹372.01 ₹515.01 ₹640.72 67
Multiples
P/E Multiple ₹795.37 ₹1,060 ₹1,326 63
P/S Multiple ₹273.60 ₹364.80 ₹456.00 58
P/B Multiple ₹248.99 ₹331.99 ₹414.98 55
EV/EBIT ₹891.71 ₹1,171 ₹1,450 66
EV/EBITDA ₹748.94 ₹980.48 ₹1,212 67
EV/Revenue ₹293.74 ₹396.34 ₹498.93 54
Asset-Based
NCAV (Graham) ₹10.24 ₹15.51 ₹19.39 54
Growth DCF
Growth DCF ₹589.20 ₹740.91 ₹911.53 80
Rev-Margin DCF ₹414.34 ₹544.19 ₹689.16 74
Economic Profit
Residual Income ₹149.96 ₹182.48 ₹288.20 74
ROIC Compounder ₹429.76 ₹476.18 ₹514.43 72
Growth Earnings
Growth-Adj P/E ₹612.24 ₹874.63 ₹1,137 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 86/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 98
How much profit the company makes from its sales and capital
Quality Growth 33
Are margins and returns getting better?
Cashflow 89
Do the profits arrive as real cash?
Financial strength 93
Debt, balance sheet and risk of trouble
Investment 90
Does it invest with discipline instead of growing at any price?
Low Volatility 76
How calm the share price moves, does not count
Price momentum 23
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 21
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 66/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−0.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.3%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.2%
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+8.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+5.1%
Dividend (yield on the price)3.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.5.1% vs 8.7%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.28% → 29%
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+22.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +17.1% a year for the price.

500830 screens overvalued: fair value 56% below the price. Compare with Hindustan Unilever Limited →

Compare Colgate-Palmolive (India) Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 241 stocks

Beats the industry median on 7/9 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 86 · Top 25%
Fair Value upside −55.7% · Bottom 25%
Profitability
Return on assets 38.9% · Top 25%
Net margin (12 months) 22.1% · Top 25%
Operating margin (12 months) 28.8% · Top 25%
Growth and dividend
Dividend yield (12 months) 3.0% · Above median

Valuation Multiplesvs Household & Personal Products median · lower = cheaper

P/E (12 months) 45.0× · Priciest 25%
P/B 0.33× · Cheapest 25%
Price / free cash flow (fiscal year) 0.3× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 35
FUTURE (revenue growth)0 · sector 20
PAST (return on equity)0 · sector 29
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)60 · sector 53

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Puig Brands, S.A PUIG €19.76 €24.28 +23% vs 500830
Henkel AG HEN €78.10 €83.75 +7% vs 500830
Beiersdorf Aktiengesellschaft, BEI €79.02 €69.09 −13% vs 500830
The Clorox Company CLX $104.90 $74.29 −29% vs 500830
Godrej Consumer Products Limited GODREJCP ₹929.50 ₹657.04 −29% vs 500830
Amorepacific Corporation 090430 142,500 KRW 84,773 KRW −41% vs 500830
Church & Dwight Co CHD $109.68 $65.04 −41% vs 500830
Marico Limited MARICO ₹918.80 ₹493.84 −46% vs 500830
The Estée Lauder Companies Inc EL $101.77 $44.21 −57% vs 500830
Hindustan Unilever Limited HINDUNILVR ₹2,074 ₹775.25 −63% vs 500830

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Colgate-Palmolive (India) Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Colgate-Palmolive (India) Limited Fair Value". https://www.fairvalue-calculator.com/stock/500830

Frequently asked questions

Is Colgate-Palmolive (India) Limited (500830) overvalued or undervalued?
As of Nov 19, 2026, our model estimates a fair value of ₹787.06 versus a price of ₹1,775, about 56% lower (overvalued).
What is the fair value of 500830?
Our model-based fair value for Colgate-Palmolive (India) Limited is ₹787.06 (as of Nov 19, 2026), built from audited fundamentals. The current price: ₹1,775.
What is the quality score of 500830?
Colgate-Palmolive (India) Limited has a Quality Score of 86/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Colgate-Palmolive (India) Limited (500830)?
We do not set a price target; the yardstick is the fair value of ₹787.06 (as of Nov 19, 2026) from 25 valuation models. Cautious scenario ₹580.07, optimistic scenario ₹1,040. It is a calculation from audited fundamentals, not an analyst target.
What is the Colgate-Palmolive (India) Limited stock forecast for 2026?
Our models put fair value at ₹787.06, about 56% lower versus a price of ₹1,775 (overvalued). Cautious scenario ₹580.07, optimistic scenario ₹1,040. The calculation is refreshed regularly with new filings.
Does Colgate-Palmolive (India) Limited pay a dividend?
Colgate-Palmolive (India) Limited currently shows a dividend yield of 2.98% relative to its recent price (as of Nov 19, 2026).
How much is the dividend of Colgate-Palmolive (India) Limited (500830)?
Colgate-Palmolive (India) Limited has a dividend yield of 3.0%.
What growth is priced into Colgate-Palmolive (India) Limited (500830)?
For today's price to be fair in a discounted-cash-flow model, Colgate-Palmolive (India) Limited would have to grow free cash flow by 22.0 % per year for five years (discount rate 12.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 4.3 % per year. As of Nov 19, 2026.
What discount rate (WACC) does the fair value of 500830 use?
Our models discount Colgate-Palmolive (India) Limited at 12.4 %: a base by market capitalisation (mid), country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Colgate-Palmolive (India) Limited that is +22.0 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.4 %) and the same formula as our fair value.
How much growth has Colgate-Palmolive (India) Limited (500830) delivered so far?
Over the past 5 years revenue at Colgate-Palmolive (India) Limited grew 4.3 % a year. The price currently implies free-cash-flow growth of +22.0 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
What is the free cash flow yield of Colgate-Palmolive (India) Limited (500830)?
The free-cash-flow yield on the price is 3.58 %: that much free cash flow Colgate-Palmolive (India) Limited produces per unit of market value. When it exceeds the discount rate of our models (12.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Colgate-Palmolive (India) Limited (500830)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Colgate-Palmolive (India) Limited it is ₹787.06 per share (as of Nov 19, 2026), against a price of ₹1,775. It is the blended result of 25 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Colgate-Palmolive (India) Limited stock overvalued or undervalued in 2026?
As of Nov 19, 2026, 500830 trades above its calculated fair value: price ₹1,775, fair value ₹787.06, a gap of about −56% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 500830?
No. The price is what the market pays today (₹1,775); the fair value is what the company's own numbers justify (₹787.06). For Colgate-Palmolive (India) Limited the two are ₹987.94 per share apart. That gap is exactly why we show both numbers side by side.
How much is Colgate-Palmolive (India) Limited worth?
The market values Colgate-Palmolive (India) Limited at about ₹483B (market capitalisation, as of Nov 19, 2026). Per share that is ₹1,775; our models calculate a fair value of ₹787.06 per share.
What do the bullish and bearish scenarios say about 500830?
Our models span a range for Colgate-Palmolive (India) Limited: cautious scenario ₹580.07, base ₹787.06, optimistic ₹1,040 per share (as of Nov 19, 2026, price ₹1,775). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 500830?
Colgate-Palmolive (India) Limited trades at a price-to-earnings ratio of 45.0 (as of Nov 19, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹787.06 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings: 43.5. Other multiples: P/B 0.3.
How far is 500830 from its 52-week high?
Colgate-Palmolive (India) Limited trades at ₹1,775, about 22% below its 52-week high of ₹2,269 and 13% above the low of ₹1,574 (as of Nov 19, 2026). Distance from the high says nothing about value: that is what the fair value of ₹787.06 is for.
Which stocks are comparable to Colgate-Palmolive (India) Limited?
From the same area (Consumer Defensive) we also value Hindustan Unilever Limited, The Estée Lauder Companies Inc, Henkel AG, Church & Dwight Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Colgate-Palmolive (India) Limited stock attractive at the current price?
The data as of Nov 19, 2026: price ₹1,775, calculated fair value ₹787.06 (−56%), Quality Score 86/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 500830 calculated?
We run Colgate-Palmolive (India) Limited through 25 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹787.06 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 11.0% above its aggregate fair value. Colgate-Palmolive (India) Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Colgate-Palmolive (India) Limited (500830)?
The closing price on Nov 19, 2026 was ₹1,775. Our model-based fair value is ₹787.06, about 56% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Colgate-Palmolive (India) Limited right now?
A high-quality business (quality 86/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. The price sits above even our optimistic bull case (₹1,040). The favourable scenario is already priced in.

Key figures of Colgate-Palmolive (India) Limited

How large is the market capitalisation of Colgate-Palmolive (India) Limited (500830)?
The market capitalisation of Colgate-Palmolive (India) Limited is ₹483B (≈ $5.2B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Colgate-Palmolive (India) Limited (500830)?
The price-to-sales ratio of Colgate-Palmolive (India) Limited is 9.96 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Colgate-Palmolive (India) Limited (500830)?
Earnings per share at Colgate-Palmolive (India) Limited are ₹38.07 (price ÷ EPS = P/E 45.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Colgate-Palmolive (India) Limited (500830)?
The dividend yield of Colgate-Palmolive (India) Limited is 3.0% (payout 139%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Colgate-Palmolive (India) Limited (500830)?
The net margin of Colgate-Palmolive (India) Limited is 22.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Colgate-Palmolive (India) Limited (500830)?
The return on equity (ROE) of Colgate-Palmolive (India) Limited is 7,503% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Colgate-Palmolive (India) Limited (500830)?
On an EBIT basis the return on assets of Colgate-Palmolive (India) Limited is 51.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
Free · no account needed

Watch Colgate-Palmolive (India) Limited in the live analysis

One click puts Colgate-Palmolive (India) Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.